Categories: Business

Success at the Corona vaccine: Biontech and Pfizer fast high

Success at the Corona vaccine
Biontech and Pfizer fast high

Price jump for the shares of the Mainz biopharmaceutical company Biontech. Photo: Andreas Arnold/dpa

© dpa-infocom GmbH

The German manufacturer of Biontech and the US Corporation Pfizer present promising interim results of a large study for a Corona-Imfstoff. This has a prompt on the share prices.

The prospect of a vaccine against the Coronavirus has brought on Monday Pfizer and Biontech high price gains.

The papers of the US technology stock exchange Nasdaq-listed Mainz-based Biotech company Biontech jumped in the top 25 percent, to 115 US dollars upwards. However, you gave a part of those gains and were last with 10 percent. Shares of the Pharma heavyweight Pfizer increased by 8.7 percent.

An effective Corona vaccine in Europe and the USA is now within reach: As the first Western manufacturer Biontech and Pfizer published on Monday, promising results for the pivotal study. Thus, your vaccine provides more than 90 percent protection against the disease Covid-19. Serious side effects had not yet been registered, it was said by the two companies.

The more than 90 percent of the estimated efficiency is impressive, wrote Analyst Chris Schott from the investment Bank JPMorgan in a first reaction to the news. It suggests that there could be a breakthrough in the fight against the pandemic.

Efficacy of the vaccine candidates from more than 90 percent was higher than expected, wrote Analyst Carter Gould from Barclays Bank. The result should contribute to concerns about the effectiveness and the General Impfbereitschaft address. Other vaccines that are currently researched to combat the Virus and developed, could show a higher effectiveness than previously thought, said Gould.

Something of a cautious Analyst Zhiqiang Shu of the Berenberg Bank argued. The efficiency requirements of the US food and drug administration, FDA, is likely to be exceeded, with an effectiveness of 90 percent, although loose. In addition, it concerns so far, no serious security. There are other questions remained open, such as the duration of protection. Some of these questions could probably be answered after you have been admitted.

dpa
Matthew Velter

With 5 years of experience as an editor, Matthew has been a crucial part of eTrendy Stock since its inception. He looks after the editing of news content published on eTrendy Stock. Apart from investing his time in editing, he also provides well-researched news articles for the U.S. niche. Mathew studied at University of central Florida.

Recent Posts

Sunny Mining Unveils Weekend Incentive Contracts for Short-Term Crypto Profits

Los Angeles, California, 22nd August 2025, ZEX PR WIRE, As digital assets gain increasing attention,…

1 day ago

Price pullbacks are no longer the end: APT miners help XRP investors lock in daily gains

Los Angeles, California, 22nd August 2025, ZEX PR WIRE, After XRP once again fell below…

1 day ago

Irys Raises $10M Series A to Unlock $3 Trillion Data Economy With First Programmable Datachain

CoinFund-Led Round Accelerates Institutional Adoption of Infrastructure For Datachains London, UK, Aug 22, 2025, ZEX…

1 day ago

BJMINING Attracts Thousands of New Users Amid Crypto Rally, Delivering $7,000 Daily Returns

London, UK, 22nd August 2025, ZEX PR WIRE- With the launch of Bitcoin and Ethereum…

1 day ago

XRP holders cash out $5,777 per day through secure blockchain cloud mining.

Start your journey to wealth with one click. Miami, Florida, 22nd August 2025, ZEX PR…

1 day ago

PlanMining Helps XRP Investors Earn $8,800 in Passive Income Daily

London, England, 22nd August 2025, ZEX PR WIRE, In today’s volatile cryptocurrency market, maintaining asset…

1 day ago